Methotrexate vs Montelukast
Methotrexate vs Montelukast: Overview
This comparison examines the pharmacological differences between Methotrexate and Montelukast.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Montelukast: Selective leukotriene D4 receptor antagonist.
Pharmacokinetics
Half-life: Methotrexate β 3-10 hours; Montelukast β 2.7-5.5 hours.
Chemical Properties
Molecular Formula: Methotrexate β C20H22N8O5; Montelukast β C35H36ClNO3S.
Molecular Weight: Methotrexate β 454.4400 g/mol; Montelukast β 586.1800 g/mol.
Type: Methotrexate β Small molecule; Montelukast β Small molecule.